Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries

NCT ID: NCT03657394

Last Updated: 2025-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

3442 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-17

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators will conduct a study on non-vigorous infants at birth to determine if umbilical cord milking (UCM) results in lower rate of moderate to severe hypoxic ischemic encephalopathy (HIE) or death than early clamping and for infants who are non-vigorous at birth and need immediate resuscitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypoxic-ischemic encephalopathy (HIE) is a brain injury caused by inadequate blood flow and oxygen delivery to the neonatal brain. Almost all infants with severe HIE and 30-50% infants with moderate HIE either die or develop significant developmental delay, cerebral palsy or other disabilities.The incidence of HIE is 1-3 per 1,000 term births in developed countries and 15-20 times higher in developing countries (Worldwide, 0.5 to 1 million infants develop HIE each year). Therapeutic hypothermia is the only proven therapy for infants with HIE. Even after receiving therapeutic hypothermia, one-half of all infants with moderate and severe HIE die or develop neurological and functional impairment. Therapeutic hypothermia is not widely available and ineffective in developing nations.There is an urgent need for a new therapy for neonates with HIE, which can complement hypothermia and be readily available in developing nations. Stem cell transplantation is a potential therapy for infants with HIE. Umbilical cord blood is a rich source of stem cells. Umbilical cord milking (UCM) may have similar effect as autologous umbilical cord blood cell transplantation.

Preliminary evidence suggests a placental transfusion in term infants may be a neuroprotective mechanism that can also facilitate cardiovascular transition for neonates depressed at birth and result in decreased mortality and improved neurodevelopmental outcomes. Infants with HIE, due to varied complications during the birth process, have poor perfusion due to fetal blood volume loss to the placenta. However, the most common method of providing placental blood, delayed cord clamping (DCC) cannot be performed since infants with HIE are non-vigorous and providers often need to perform resuscitation immediately after birth. The World Health Organization and the American College of Obstetrics and Gynecology (ACOG) also does not recommended DCC in neonates who are non-vigorous (limp, pale, and not breathing) at birth and require immediate resuscitation. Umbilical cord milking (UCM) or gently squeezing cord blood toward the baby, is an alternative to DCC, which can achieve significant placental transfusion without delaying resuscitation. Further, UCM can be completed as quickly as immediate cord clamping (ICC) and UCM requires minimal training and no additional staff.

The investigators hypothesized that UCM will reduce the number of infants developing moderate to severe HIE or death in neonates who are non-vigorous at birth compared to early cord clamping (ECC). This will be a cluster crossover randomized controlled trial. Each hospital will be randomly assigned to use either ECC or UCM for any infant who is non-vigorous at birth and needing resuscitation over a period of 6 months. Then the site will change to the other method for an additional 6 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoxic-Ischemic Encephalopathy Birth Asphyxia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Placental transfusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Cluster Randomized Crossover
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Umbilical Cord Milking

The delivering practitioner will place the newborn below the level of the incision (at the edge of the table) at C/S and a second team member will milk the cord four times. For vaginal delivery, the delivering obstetrician, midwife or perinatal provider will hold the infant against their body or place the infant on the mother's abdomen and the cord will be milked either four times by the obstetrical provider or by a second team member. For the cord milking procedure, the obstetrical provider will milk 20-30 centimeters length of the umbilical cord over two seconds, repeating three additional times as described previously. This time is not significantly different from the time for ECC.

Group Type ACTIVE_COMPARATOR

Umbilical cord milking

Intervention Type OTHER

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 1--15 seconds.

Early Cord Clamping

Umbilical cord will be clamped immediately after birth (within 60 seconds)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Umbilical cord milking

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 1--15 seconds.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non-vigorous neonates born between 35-42 weeks

Exclusion Criteria

* Congenital malformation of CNS.
* Chromosomal abnormalities.
* Major congenital malformations.
* Abruption/cutting through the placenta at delivery.
* Umbilical cord knots or inadequate cord length.
* Mono-chorionic twins or twins with no information on amnion/chorion.
* Multiple gestation \>2 .
Minimum Eligible Age

35 Weeks

Maximum Eligible Age

42 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sharp HealthCare

OTHER

Sponsor Role collaborator

Thomas Jefferson University

OTHER

Sponsor Role collaborator

University of San Diego

OTHER

Sponsor Role collaborator

St. Louis University

OTHER

Sponsor Role collaborator

Jawaharlal Nehru Medical College

OTHER

Sponsor Role collaborator

Daga Memorial Maternity and Children's Hospital, Nagpur, India

UNKNOWN

Sponsor Role collaborator

Mahatma Gandhi Institue of Medical Sciences, Wardha, India

UNKNOWN

Sponsor Role collaborator

Karnataka Institue of Medical Sciences, Hubbali, India

UNKNOWN

Sponsor Role collaborator

Jawaharlal Institute of Postgraduate Medical Education & Research

OTHER_GOV

Sponsor Role collaborator

All India Institute of Medical Sciences

OTHER

Sponsor Role collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

Sponsor Role collaborator

Indira Gandhi Government Medical College & Hospital, Nagpur, India

UNKNOWN

Sponsor Role collaborator

Pimpri Chinchwad Municipal Corporation's Post-Graduate Institute, Yashwantrao Chavan Memorial Hospital, Pune, India

UNKNOWN

Sponsor Role collaborator

Government Medical College, Nagpur

INDUSTRY

Sponsor Role collaborator

Nemours Children's Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zubair Aghai

Professor Of Pediatrics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zubair H Aghai, MD

Role: PRINCIPAL_INVESTIGATOR

Nemours Children's Clinic

Anup Katheria, MD

Role: PRINCIPAL_INVESTIGATOR

Sharp Mary Birch Hospital for Women & Newborns

Sangappa Dhaded, MD

Role: PRINCIPAL_INVESTIGATOR

KLE Academy of Higher Education and Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KLE Academy of Higher Education and Research (Deemed-to-be-University) Jawaharlal Nehru Medical College

Belagavi, Karnataka, India

Site Status

Indira Gandhi Government Medical College & Hospital

Nagpur, Maharashtra, India

Site Status

Pimpri Chinchwad Municipal Corporation's Post-Graduate Institute, Yashwantrao Chavan Memorial Hospital

Pune, Maharashtra, India

Site Status

Government Medical College

Chandrapur, MS, India

Site Status

Daga Memorial Woman and Children Hospital

Nagpur, MS, India

Site Status

Government Medical College and Hospital

Nagpur, MS, India

Site Status

All India Institute of Medical Science

Nagpur, MS, India

Site Status

Mahatma Gandhi Institute of Medical Sciences/ Kasturba Hospital

Wardha, MS, India

Site Status

Sawai Man Singh (SMS) Medical College

Jaipur, Rajasthan, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01HD102967

Identifier Type: NIH

Identifier Source: secondary_id

View Link

CORDMILK

Identifier Type: -

Identifier Source: org_study_id